細胞裂解與破碎市場規模、佔有率及成長分析：依產品類型、方法、細胞類型、應用、最終用戶與地區分類－2026-2033年產業預測

2024 年全球細胞裂解和破碎市場價值為 68 億美元，預計到 2025 年將成長至 74.3 億美元，到 2033 年將成長至 151.4 億美元，預測期（2026-2033 年）複合年成長率為 9.3%。

全球細胞裂解和破碎市場涵蓋用於破碎細胞以提取細胞內成分的儀器、試劑和耗材，這些成分對於研究和工業應用至關重要。推動這項市場需求的因素包括提取藥物研發、診斷和生物製造所需的蛋白質、核酸和代謝物。調查方法的進步促使人們從手動操作轉向高度機械化的方法，例如超音波破碎儀、高壓均質器以及用於提高重複性的酵素試劑盒。該市場的主要成長要素之一是自動化、高通量裂解平台的發展趨勢。這種平台能夠處理大量樣本，並縮短疫苗製劑和蛋白質體學研究的處理時間。這項轉變提高了營運效率和合規性，同時也為全球供應商和服務供應商創造了新的機會。

全球細胞裂解和破碎市場按產品類型、方法、細胞類型、應用、最終用戶和地區進行細分。依產品類型分類，市場分為儀器和試劑及耗材兩大類。依方法分類，市場分為機械破碎和非機械破碎兩大類。依細胞類型分類，市場分為哺乳動物細胞、細菌細胞、酵母/真菌/藻類細胞和植物細胞。按應用分類，市場分為蛋白質分離、核酸分離、細胞器分離、下游加工、診斷和臨床應用以及藥物發現和開發。按最終用戶分類，市場分為製藥和生物技術公司、學術和研究機構、醫院和診斷檢查室、細胞庫、合約研究和生產機構以及其他機構。依地區分類，市場分為北美、歐洲、亞太、拉丁美洲以及中東和非洲。

全球細胞裂解和破碎市場的成長要素

全球細胞裂解和破碎市場正經歷顯著成長，這主要得益於生物製藥研發投入的增加。這促使藥物發現和製程開發領域的資金投入不斷成長。製造商和研究機構正優先考慮高效的樣品製備和下游製程方法，以最佳化蛋白質產量、維持蛋白質完整性並加速新候選物質的篩檢。此外，滿足不同細胞類型和工作流程的需求也推動了對可擴展且穩定的裂解和破碎技術的需求。隨著持續的研發投入推動創新，供應商正在不斷強化其產品線，以確保不斷發展的技術能持續推動市場擴張。

全球細胞裂解和破碎市場的限制因素

全球細胞裂解和破碎市場面臨許多限制因素，包括先進裂解設備的高資本投資成本，以及耗材、維護和驗證等持續性支出。這往往降低了先進解決方案的吸引力，甚至使小規模實驗室和新興市場實驗室難以獲得這些解決方案。預算限制導致人們依賴成熟且經濟高效的方法，從而限制了高階技術的應用，儘管這些技術具有潛在的長期效益。此外，維護需求的複雜性以及對熟練人員的需求也使採購決策變得複雜，導致設備更換週期延長，以及不同地區和組織部門採用新設備的速度放緩。

細胞裂解和破碎市場的全球趨勢

全球細胞裂解和破碎市場正呈現出顯著的自動化和高通量解決方案趨勢，這些解決方案能夠顯著提升實驗室工作流程。機器人操作設備和自動化流體處理系統的整合正在革新樣品處理方式，在減少人工操作的同時，提高了不同細胞類型和培養基的可重複性和一致性。這種轉變使得可擴展的篩檢流程成為可能，縮短了檢測時間，並實現了高效的下游純化步驟。透過最大限度地減少操作人員的差異，這些進步正在加速藥物和生技藥品的發現和開發，最終推動細胞裂解和破碎領域的成長和創新。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球細胞裂解與破碎市場規模：依產品類型分類

• 裝置
  • 均質機
  • 超音波破碎裝置
  • 珠磨機
  • 法式濾壓系統
  • 微射流發生器
  • 其他
• 試劑和耗材
  • 清潔劑和界面活性劑
  • 酵素
  • 緩衝液/溶液
  • 珠子和研磨介質
  • 試劑盒和檢測試劑
  • 其他

全球細胞裂解與破碎市場規模：依方法分類

• 機械破碎
  • 化學溶解
  • 酵素溶解
  • 滲透壓溶解
  • 熱熔膠
• 非機械破碎

全球細胞裂解與破碎市場規模：依細胞類型分類

• 哺乳動物細胞
• 細菌細胞
• 酵母菌
• 真菌和藻類細胞
• 植物細胞

全球細胞裂解與破碎市場規模：按應用領域分類

• 蛋白質分離
• 核酸萃取
• 細胞器分離
• 下游工藝
• 診斷和臨床應用
• 藥物發現與開發

全球細胞裂解與破碎市場規模：依最終用戶分類

• 製藥和生物技術公司
• 學術研究機構
• 醫院/診斷檢查室
• 細胞庫
• 合約研究和製造組織
• 其他

全球細胞裂解和破碎市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Thermo Fisher Scientific Inc.
• Merck KGaA
• Danaher Corporation
• Bio-Rad Laboratories, Inc.
• QIAGEN NV
• F. Hoffmann-La Roche Ltd.
• Becton, Dickinson and Company
• Miltenyi Biotec GmbH
• Agilent Technologies, Inc.
• Eppendorf SE
• Promega Corporation
• Takara Bio Inc.
• New England Biolabs, Inc.
• Covaris, LLC
• Qsonica LLC
• Claremont BioSolutions, LLC
• Parr Instrument Company
• Cell Signaling Technology, Inc.
• Microfluidics International Corporation
• Revvity, Inc.

結論與建議

Global Cell Lysis & Disruption Market size was valued at USD 6.8 Billion in 2024 and is poised to grow from USD 7.43 Billion in 2025 to USD 15.14 Billion by 2033, growing at a CAGR of 9.3% during the forecast period (2026-2033).

The global cell lysis and disruption market consists of instruments, reagents, and consumables designed to break open cells for the extraction of intracellular content, crucial for research and industrial applications. The demand is driven by the need to extract proteins, nucleic acids, and metabolites, which are essential for drug discovery, diagnostics, and biomanufacturing. Advances in methodology have transitioned from manual techniques to sophisticated mechanized approaches, including sonicators and high-pressure homogenizers, along with enzyme-based kits for enhanced reproducibility. A significant growth factor in this market is the trend towards automated high-throughput lysis platforms, enabling consistent results for large sample volumes and quicker turnaround times in vaccine formulation and proteomic studies. This shift enhances operational efficiency and regulatory compliance while presenting new opportunities for global suppliers and service providers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Lysis & Disruption market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Lysis & Disruption Market Segments Analysis

Global cell lysis & disruption market is segmented into product type, technique, cell type, application, end user and region. Based on product type, the market is segmented into Instruments and Reagents & Consumables. Based on technique, the market is segmented into Mechanical Disruption and Non-Mechanical Disruption. Based on cell type, the market is segmented into Mammalian Cells, Bacterial Cells, Yeast, Fungi & Algae Cells and Plant Cells. Based on application, the market is segmented into Protein Isolation, Nucleic Acid Isolation, Cell Organelle Isolation, Downstream Processing, Diagnostics & Clinical Applications and Drug Discovery & Development. Based on end user, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Laboratories, Cell Banks, Contract Research & Manufacturing Organizations and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Lysis & Disruption Market

The global Cell Lysis and Disruption market is witnessing notable growth, largely fueled by the rising focus on biopharmaceutical research, which has led to increased funding for discovery and process development. Manufacturers and research institutions prioritize efficient sample preparation and downstream processing methods to optimize protein yields, preserve protein integrity, and expedite the screening of new candidates. Furthermore, the growing demand for scalable and consistent lysis and disruption techniques stems from the need to accommodate diverse cell types and workflows. As ongoing research and development efforts propel innovation, suppliers are enhancing their product offerings, ensuring that the evolving technologies continue to drive market expansion.

Restraints in the Global Cell Lysis & Disruption Market

The Global Cell Lysis & Disruption market faces significant constraints due to high capital costs associated with advanced lysis instruments, coupled with ongoing expenses for consumables, maintenance, and validation. This often makes sophisticated solutions less appealing or even inaccessible for smaller laboratories and those in emerging markets. Such budget limitations lead to a reliance on established or cost-effective methods, which may have long-term benefits, thereby restricting the adoption of high-end technologies. Additionally, the perception of complex maintenance requirements and the necessity for skilled personnel complicate purchasing decisions, resulting in extended replacement cycles and slower adoption rates of new equipment across various geographic and organizational segments.

Market Trends of the Global Cell Lysis & Disruption Market

The Global Cell Lysis & Disruption market is witnessing a significant trend towards automation and high-throughput solutions that enhance laboratory workflows. The integration of robotic handlers and automated liquid handling systems is revolutionizing sample processing, reducing manual labor while increasing reproducibility and consistency across varied cell types and media. This shift is resulting in shorter assay turnaround times and scalable screening processes that allow for efficient downstream purification stages. By minimizing operator variability, these advancements are expediting drug and biologic discovery and development, ultimately driving growth and innovation within the cell lysis and disruption sector.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Cell Lysis & Disruption Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Instruments
  • Homogenizers
  • Sonicators
  • Bead Mills
  • French Press Systems
  • Microfluidizers
  • Others
• Reagents & Consumables
  • Detergents & Surfactants
  • Enzymes
  • Buffers & Solutions
  • Beads & Grinding Media
  • Kits & Assay Reagents
  • Others

Global Cell Lysis & Disruption Market Size by Technique & CAGR (2026-2033)

• Market Overview
• Mechanical Disruption
  • Chemical Lysis
  • Enzymatic Lysis
  • Osmotic Lysis
  • Thermal Lysis
• Non-Mechanical Disruption

Global Cell Lysis & Disruption Market Size by Cell Type & CAGR (2026-2033)

• Market Overview
• Mammalian Cells
• Bacterial Cells
• Yeast
• Fungi & Algae Cells
• Plant Cells

Global Cell Lysis & Disruption Market Size by Application & CAGR (2026-2033)

• Market Overview
• Protein Isolation
• Nucleic Acid Isolation
• Cell Organelle Isolation
• Downstream Processing
• Diagnostics & Clinical Applications
• Drug Discovery & Development

Global Cell Lysis & Disruption Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutes
• Hospitals & Diagnostic Laboratories
• Cell Banks
• Contract Research & Manufacturing Organizations
• Others

Global Cell Lysis & Disruption Market Size & CAGR (2026-2033)

• North America (Product Type, Technique, Cell Type, Application, End User)
  • US
  • Canada
• Europe (Product Type, Technique, Cell Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Technique, Cell Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Technique, Cell Type, Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Technique, Cell Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Covaris, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Qsonica LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Claremont BioSolutions, LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parr Instrument Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cell Signaling Technology, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microfluidics International Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revvity, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations